Difference between revisions of "CD20"
Jump to navigation
Jump to search
| Line 6: | Line 6: | ||
| Abbrev = | | Abbrev = | ||
| Synonyms = | | Synonyms = | ||
| Similar = CD79a | | Similar = CD79a, PAX5 | ||
| Clones = | | Clones = | ||
| Use = B-cell lymphomas | | Use = B-cell lymphomas | ||
Revision as of 15:49, 5 March 2017
| CD20 | |
|---|---|
| Immunostain in short | |
| Similar stains | CD79a, PAX5 |
| Use | B-cell lymphomas |
| Subspeciality | hematopathology |
| Positive | most B-cell lymphomas |
CD20 is a B-cell marker. It is positive in most B-cell lymphoma.
Lymphomas
Negative B cell lymphomas
- Plasmablastic lymphoma.[1]
- ALK+ large B-cell lymphoma.
- Classical Hodgkin's lymphoma.
Abberant faint positive
- T-cell lymphoma/leukemia - rare.[2]
See also
References
- ↑ Teruya-Feldstein, J.; Chiao, E.; Filippa, DA.; Lin, O.; Comenzo, R.; Coleman, M.; Portlock, C.; Noy, A. (Nov 2004). "CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients.". Ann Oncol 15 (11): 1673-9. doi:10.1093/annonc/mdh399. PMID 15520070.
- ↑ Kawano, R.; Niino, D.; Ohshima, K. (2016). "Six Cases of CD20-Positive Adult T-Cell Leukemia.". J Clin Exp Hematop 56 (2): 119-125. doi:10.3960/jslrt.56.119. PMID 27980301.